Abstract
Overweight and obesity are risk factors for several co-morbidities reducing life expectancy. Conservative treatment of obesity is generally ineffective in the long-term. Bariatric surgery has proven effective, but is associated with potential complications. Duodenal-jejunal bypass sleeve is a novel minimal invasive and fully reversible endoscopic treatment modality approved for treatment of obesity with or without concomitant type 2 diabetes. Here we review present data for the efficacy and safety of this treatment modality.
| Bidragets oversatte titel | Duodenal-jejunal bypass sleeve - a potential alternative to bariatric surgery? |
|---|---|
| Originalsprog | Dansk |
| Tidsskrift | Ugeskrift for læger [online] |
| Vol/bind | 176 |
| Udgave nummer | 37 |
| ISSN | 1603-6824 |
| Status | Udgivet - 8 sep. 2014 |